The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
64Cu-DOTA-trastuzumab PET/CT to predict response to ado-trastuzumab emtansine (TDM1) in HER2-positive metastatic breast cancer.
 
Joanne E. Mortimer
Honoraria - Novartis (I)
Consulting or Advisory Role - Puma Biotechnology
Speakers' Bureau - Novartis (I)
Research Funding - Cephalon; Novartis
Other Relationship - Novo Nordisk
 
James R. Bading
No Relationships to Disclose
 
Paul Henry Frankel
No Relationships to Disclose
 
Rita Gidwaney
No Relationships to Disclose
 
John Park
No Relationships to Disclose
 
Lusine Tumyan
No Relationships to Disclose
 
Maria Parayno
No Relationships to Disclose
 
Kofi Poku
No Relationships to Disclose
 
David Colcher
No Relationships to Disclose